查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853421

医疗组件製造市场（按活性成分、给药装置、包装组件、诊断设备组件、手术器材、生物相容性材料和辅料划分）－全球预测（2025-2032年）

Medical Component Manufacturing Market by Active Ingredients, Drug Delivery Devices, Packaging Components, Diagnostic Equipment Components, Surgical Instruments, Biocompatible Materials, Excipients - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医疗组件製造市场规模将成长 250 亿美元，复合年增长率为 6.24%。

关键市场统计数据
基准年 2024 153.9亿美元
预计年份：2025年 163.4亿美元
预测年份 2032 250亿美元
复合年增长率 (%) 6.24%

对医疗组件製造业的高层次策略概述，重点介绍推动产业转型的技术创新、监管压力和业务重点。

医疗器材零件製造领域正处于技术创新、监管环境和不断变化的临床需求的交汇点。为製药、诊断和外科手术市场供应零件的製造商必须管理复杂的价值链，同时还要适应不断变化的原材料供应、先进的材料科学以及日益增长的品质和可追溯性要求。整个产业都迫切需要加快产品开发週期，同时又不影响合规性和病患安全，这正在改变研发、采购和製造团队的协作方式。

诸如用于植入的精密加工、用于实验室晶片的微加工以及用于定制设备的增材製造等新型製造技术，在催生新产品形态的同时，也带来了新的资格确认和验证要求。同时，用于监控生产完整性和供应链溯源的数位化工具正从试点阶段走向企业级部署。这些变化与监管机构就组合药物、生技药品处理和标籤要求展开的日益密切的讨论同步发生，要求製造商维持严格的品质系统并展现出稳健的变更管理流程。

因此，策略领导者必须优先考虑工程、品质、法规和商业团队之间的跨职能协作。这种协作能够确保创新转化为可製造的解决方案，并确保製造策略充分考虑临床需求、法规时限以及下游包装和交付方面的因素。将卓越营运与对材料和数位化能力的前瞻性投资相结合，将有助于製造商成功应对日益复杂的零件规格和终端用户期望。

技术、监管和市场力量的融合正在推动多项变革性转变，重塑医疗组件製造业。首先，生物製药和复杂组合产品的成熟提高了组件的复杂性，从而需要更严格的控制、更高的无菌保证和更严格的组件公差。这一趋势迫使製造商投资于生物製药的专业技术，并与药物研发人员紧密合作，以确保组件的兼容性。

其次，数位化品质系统和工业4.0的采用正在加速。即时监控、预测性维护和数据主导的製程控制正在提高产量比率并缩短产品上市时间，但同时也对员工技能的提升和强大的网路安全保障提出了更高的要求。第三，在全球动盪的背景下，供应链韧性已成为一项策略重点。製造商正在实现供应商多元化，寻找二手信息，并探索近岸外包方案，以降低单一来源风险。

第四，永续性考量正在影响材料选择和包装设计。这些考虑推动了塑胶减量、可回收性提升和碳排放减少，促使初级和二级包装创新，并重新评估材料生命週期。最后，法律规范也不断发展以适应新技术和产品类别，这增加了积极参与监管事务和製定适应性合规策略的必要性。这些变化共同为製造商创造了一个更复杂但也充满机会的环境，这些製造商能够将技术能力与稳健的营运和监管前瞻性相结合。

评估关税动态如何重塑零件製造商2025年的采购、供应链弹性策略

美国2025年关税政策环境的变化，为医疗零件製造商的策略规划增添了新的维度，影响成本结构、供应商选择和采购区域。关税加剧了受影响地区零件和原材料的成本压力，迫使采购商重新评估供应商合同，将关税调整后的到岸成本纳入采购模式，并加快寻找替代供应商。对于那些依赖特殊合金、精密聚合物和独特次组件的零件而言，影响尤其显着，因为这些产品的全球供应商数量有限。

为了应对关税带来的不确定性，许多组织正在采取多管齐下的应对措施。采购团队正努力完善合约条款，以纳入关税转嫁和重新谈判机制；供应链负责人则正在整理各层级的关税风险敞口，以识别关键风险节点。同时，各组织也努力推动供应链区域化，以降低跨境关税的影响。区域化有助于缩短前置作业时间，提高透明度，但可能需要对本地製造能力和品质保证基础设施进行投资。

此外，製造商正在重新评估其库存策略，以平衡库存增加带来的营运成本与关税波动带来的缓衝作用。这种调整通常涉及加强商务团队和营运团队之间的协作，以确保定价策略、客户承诺和利润管理能够反映新的成本格局。虽然关税只是影响采购决策的众多因素之一，但其存在使得人们更加关注总到岸成本分析、供应商多元化和合约弹性，并将这些视为建立稳健的原料生产策略的基石。

详细的細項分析展示了活性成分、器械类别、包装、诊断、仪器、材料和辅料类别如何决定生产和品质优先顺序。

细分市场层面的情报揭示了不同成分类型、材料和器械类别所带来的差异化商机和营运重点。活性成分分为生物製药、生物相似药和小分子药物，生物製药进一步细分为单株抗体、重组蛋白及疫苗。单株抗体和重组蛋白通常需要低蛋白结合的物料输送和高完整性密封，而疫苗可能需要特殊的初级包装容器和低温运输密封。

给药装置细分市场包括输液帮浦、吸入器、注射器和经皮吸收贴片，其中註射器又可细分为自动注射器、笔式註射器和预填充式注射器。相应地，工程重点也从输液系统的流路优化和精确计量转向注射器和吸入器的使用者人体工学设计和剂量一致性。标籤解决方案包括插页、标籤和安全封条；初级包装包括安瓿、泡壳包装、药筒和管瓶；二级包装包括纸盒、折迭式盒和多包装。这些差异体现在序列化、防伪技术和防篡改功能等方面的优先考虑因素。

诊断设备组件分为生物感测器组件、成像组件和晶片实验室平台。生物感测器包括电化学感测器、光学感测器和压电感测器；成像组件包括磁振造影线圈、超音波换能器和X射线管。手术器械分为钳子、切割器械、抓取器械和牵开器。切割器械包括切片检查穿刺器、手术刀和剪刀；抓取器械包括镊子、抓钳和套管针。生物相容性材料分为陶瓷、复合材料、金属和聚合物，其亚型包括氧化铝、生物活性玻璃、氧化锆、金属复合材料、高分子复合材料、钴铬合金、不銹钢、钛、生物活性玻璃、氧化锆、金属基复合材料、聚合物基复合材料、钴铬合金、不銹钢、钛合金、弹性体、热塑性塑料和热固性塑料，每种材料都需要独特的加工、灭菌和表面处理工艺。最后，辅料可分为粘合剂、被覆剂、崩坏、填充剂和润滑剂，其中特定的化学物质如HPMC、聚维酮、淀粉衍生物、肠溶被覆剂、薄膜被覆剂、交联崩坏、纤维素和乳糖填充剂以及润滑剂如硬脂酸镁和PEG会影响配方相容性和下游加工。

这些细分市场特有的细微差别凸显了针对性製造能力和品管的重要性。从概念到商业化生产，需要材料科学专业知识、组件设计检验，以及根据每个细分市场独特的技术和法规要求客製化供应商资格确认。那些在关键细分市场投资深厚能力，同时保持敏捷性以适应各细分市场需求的製造商，将更有能力满足不断变化的客户期望和复杂的产品规格。

采购、监管合规、製造地和供应商发展对美洲、新兴市场和亚太市场的区域策略影响

区域动态对筹资策略、监管合规路径和创新生态系统有显着影响。在美洲，成熟的製造群和完善的法规环境为高复杂度组件的近市场生产和快速商业化创造了有利条件。该地区的生态系统支援从组件设计到临床供应的一体化工作流程，并受益于毗邻主要製药和生物技术中心的优势，这些中心需要灵活的供应链和强大的品质系统。

欧洲、中东和非洲市场呈现出多元化的格局，其特点是许多欧洲市场监管严格，先进製造能力发达，以及中东地区对数位医疗领域的投资不断增长。该地区的监管力度促使企业儘早并持续参与合格评定流程，欧洲先进材料供应商通常在特种合金和生物相容性陶瓷领域处于领先地位。这些市场的多样性要求企业采取灵活的商业性策略和针对特定区域的合规策略，以适应不同的市场准入条件和采购规范。

亚太地区一直是製造业规模化发展的重点区域，无论是成熟的契约製造製造商还是拥有成本优势的新兴本地供应商都对其青睐有加。该地区虽然有利于采购大批量零件和原材料，但日益完善的国内法规也提高了对品管系统的要求。因此，在亚太地区营运的企业必须平衡成本效益与供应商开发、品质保证和物流的投资，以确保为全球和区域客户提供可靠的供应。了解这些区域差异将有助于企业就生产地点、供应商合作关係和投资重点做出明智的决策。

竞争格局分析，重点在于塑造技术深度、卓越营运、一体化产品和服务以及市场领导地位的策略伙伴关係。

零件製造企业的竞争动态取决于它们能否将技术深度、扩充性的生产能力和完善的品质系统相结合。领先企业透过投资先进材料科学、精密製造技术和整合检验能力来脱颖而出，从而加快复杂零件的上市速度。零件製造商与药品和医疗设备开发商之间的策略伙伴关係日益普遍，这有助于儘早参与可製造的设计，并简化监管审批流程。

能够展现稳定产量比率、检验供应链和完善文件的製造商，能够获得长期合约和高端市场定位。同时，包装和防伪措施的创新，例如安全标籤和序列化技术，也为那些能够确保产品在整个分销管道中完整性的公司带来了商业性优势。对自动化和数位化品质系统的投资，能够在保持可追溯性和合规性的同时，提高生产效率，这对于拥有复杂组合药物和生物製药的客户来说尤其具有吸引力。

竞争的另一个维度在于能否提供涵盖材料、竞争性製造、组装和包装的端到端解决方案。能够整合这些能力的公司可以降低客户整合风险并加快专案进度。此外，能够灵活应对政策变化（例如关税调整）并扩大产能以满足需求激增的公司，其市场地位也至关重要。总而言之，这些能力共同构成了竞争格局，并为寻求提升市场相关性和韧性的公司提供了蓝图。

为高阶主管提供可操作的策略性倡议，以加强材料能力、供应商韧性、数位化品质系统、永续性和监管参与。

产业领导者必须采取果断行动，投资于能够满足复杂治疗方法和医疗设备不断变化的需求的能力。首先，应优先投资于生物相容性组件以及高精度成像和感测器组件的专用物料输送和製造能力，确保拥有能够进行无菌加工、严格控制公差并采用经验证的灭菌方法的设施和人员。其次，应加强供应商多元化和资格认证计划，以降低关税带来的风险和单一来源风险。

第三，我们将加快数位转型倡议，以支援即时品质监控、预测性维护和端到端可追溯性。第四，为满足买家期望和监管压力，我们将把永续性标准纳入材料选择和包装设计，并在适当情况下考虑循环经济原则。第五，为简化复杂零件和组合产品的市场进入流程，我们将加强监管参与策略，在产品开发初期就制定监管路径，并与认证机构保持积极对话。

最后，要积极寻求策略伙伴关係，以实现共同开发、共用检验和加速商业化。无论是透过供应商联盟、学术合作或合约开发安排，这些伙伴关係都能在分散风险的同时，加速能力建构。透过平衡短期因应措施与对技术、人才和伙伴关係关係的长期投资，企业主管可以满足对日益复杂的医疗组件的需求。

本文描述了一种混合方法研究途径，该方法结合了相关人员访谈、工厂检验、监管审查和分析框架，旨在获得可操作的见解。

本研究整合了来自一手和二手研究管道的定性和定量数据，对製造业、供应链、市场细分、区域动态和竞争定位进行了结构化分析。一手数据包括对製造业领导者、品质和法规专家、采购负责人以及产品开发专家的访谈，从而获得了关于营运挑战、能力需求和策略重点的第一手观点。此外，还辅以工厂观察和技术概况分析，以检验能力主张并评估其对製造流程和材料选择的实际影响。

二次研究考察了监管指导文件、医疗设备和药品组件製造标准、行业白皮书以及关于先进材料和诊断组件的技术文献。调查方法包括将初步发现与已记录的标准进行交叉检验，以确保事实准确性并识别新兴最佳实践。所使用的分析框架包括基于细分的能力映射、供应链风险评估和技术准备评估，以阐明每个类别组件的营运影响。

为维持客观性，本研究采用一致的标准评估供应商，包括生产能力、品质系统成熟度以及在受监管市场的业绩记录。鑑于专有数据和快速变化的监管政策可能限制结果的解读，本研究承认这些局限性，并制定了在市场条件发生合理变化时仍能有效适用的建议。综上所述，这些方法旨在为製造商及其合作伙伴的策略和营运决策提供支援。

总结性结论强调了能力整合、供应链韧性和监管一致性对于确保长期竞争优势的重要性。

医疗器材零件製造业正经历着一个复杂度不断提升且机会无限的时期。材料、积层製造、感测器和数位化品质系统等领域的技术进步，使得高性能零件得以实现；同时，监管要求和永续性指令也提高了合规性和生命週期管理方面的标准。供应链中断和贸易政策的转变凸显了多元化筹资策略和严格风险管理的重要性。在此背景下，那些兼具深厚技术实力、稳健营运和积极参与监管事务的製造商，将更有可能获得最持久的竞争优势。

领导者应采取组合式策略，平衡短期韧性投资（例如供应商多元化和关税敏感型采购）与先进材料和数位化製造等长期能力建设。工程、品质、法规和商业团队之间的跨职能协作对于将创新转化为可扩展且合规的产品至关重要。透过将策略性投资与特定细分市场的需求和区域实际情况相匹配，企业可以加快产品上市速度，提高产品可靠性，并加强客户伙伴关係。

总之，未来发展需要在技术、营运和管治方面执行。那些行动清晰明确、目标明确，同时又能灵活适应不断变化的临床和政策环境的製造商，更有可能在医疗组件生态系统中建立持久的竞争优势。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 生物相容性3D列印材料在病患客製化植入和器械的应用日益广泛
  • 关于频繁接触的医疗设备零件抗菌表面涂层的新规定
  • 透过整合柔性电子製造技术，朝着小型化穿戴式感测器的方向发展
  • 紧急医疗和诊断设备对硅基密封件和管材的需求日益增长。
  • 投资于不銹钢外科器械零件的自动化精密加工
  • 医疗影像硬体用稀土元素供应链韧性策略
  • 开发用于临时整形外科固定装置的生物可吸收聚合物混合物
  • 将支援物联网的微控制器整合到一次性医疗诊断盒中
  • 永续性倡议旨在推广医疗设备的可回收包装组件。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依活性成分分類的医疗组件製造市场

  • 生物製药
    • 单株抗体
    • 重组蛋白
    • 疫苗
  • 生物相似药
  • 小分子

第九章 依药物输送装置分類的医疗器材製造市场

  • 点滴帮浦
  • 吸入器
  • 注射器
    • 自动注射器
    • 笔式註射器
    • 预填充式注射器
  • 经皮吸收贴片

第十章 依包装组件分類的医疗组件製造市场

  • 标籤解决方案
    • 插入
    • 标籤
    • 安全封条
  • 初级包装
    • 安瓿
    • 泡壳包装
    • 墨水匣
    • 管瓶
  • 二级包装
    • 纸盒
    • 折迭式盒
    • 多包装

第十一章 诊断设备组件的医疗组件製造市场

  • 生物感测器组件
    • 电化学感测器
    • 光学感测器
    • 压电感测器
  • 影像组件
    • 核磁共振线圈
    • 超音波换能器
    • X射线管
  • 实验室晶片

第十二章 外科器械医疗器材製造市场

  • 夹钳
  • 切割设备
    • 切片检查穿刺
    • 女性
    • 剪刀
  • 抓取装置
    • 钳子
    • 抓钳
    • 套管针
  • 牵开器

第十三章 生物相容性材料在医疗器材製造市场的应用

  • 陶瓷
    • 氧化铝
    • 生物活性玻璃
    • 氧化锆
  • 复合材料
    • 金属复合材料
    • 高分子复合材料
  • 金属
    • 钴铬合金
    • 不銹钢
    • 钛合金
  • 聚合物
    • 弹性体
    • 热塑性塑料
    • 热固性树脂

第十四章 依辅料分類的医疗组件製造市场

  • 活页夹
    • HPMC
    • 聚维酮
    • 淀粉
  • 涂层
    • 肠溶衣
    • 薄膜涂层
    • 糖霜
  • 崩坏
    • 交联羧甲基纤维素
    • 交联聚维酮
    • 羧甲基淀粉钠
  • 填料
    • 纤维素
    • 乳糖
    • 淀粉
  • 润滑剂
    • 硬脂酸镁
    • 佩格
    • 硬脂酸

第十五章 各地区医疗器材製造市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 医疗组件製造市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国医疗器材製造市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Abbott Laboratories
    • Johnson & Johnson
    • Siemens Healthineers AG
    • GE HealthCare Technologies Inc
    • Koninklijke Philips NV
    • Becton Dickinson and Company
    • Stryker Corporation
    • Baxter International Inc
    • Boston Scientific Corporation
Product Code: MRR-3A2E844FDDF1

The Medical Component Manufacturing Market is projected to grow by USD 25.00 billion at a CAGR of 6.24% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 15.39 billion
Estimated Year [2025] USD 16.34 billion
Forecast Year [2032] USD 25.00 billion
CAGR (%) 6.24%

High-level strategic overview of medical component manufacturing highlighting innovation, regulatory pressures, and operational priorities driving industry transformation

The medical component manufacturing landscape sits at the intersection of technological innovation, regulatory scrutiny, and evolving clinical needs. Manufacturers that supply components to the pharmaceutical, diagnostic, and surgical markets must manage complex value chains while adapting to shifts in raw material availability, advanced materials science, and higher expectations for quality and traceability. Across the industry, there is a palpable imperative to accelerate product development cycles without compromising compliance or patient safety, and this imperative is reshaping how R&D, procurement, and manufacturing teams collaborate.

Emerging manufacturing techniques, such as precision machining for implants, microfabrication for lab-on-a-chip components, and additive manufacturing for bespoke instruments, are enabling new product forms while introducing new qualification and validation demands. Meanwhile, digital tools for monitoring production integrity and supply chain provenance are moving from pilot phases to enterprise deployments. These changes are occurring alongside intensified regulatory dialogues around combination products, biologics handling, and labeling requirements, which require manufacturers to maintain rigorous quality systems and to demonstrate robust change control processes.

Consequently, strategic leaders must prioritize cross-functional alignment between engineering, quality, regulatory, and commercial teams. This alignment ensures that innovations translate into manufacturable solutions and that manufacturing strategies account for clinical needs, regulatory timelines, and downstream packaging and delivery considerations. By integrating operational excellence with forward-looking investment in materials and digital capabilities, manufacturers can better navigate the growing complexity of component specifications and end-user expectations.

Several transformative shifts are redefining the medical component manufacturing sector, driven by converging technological, regulatory, and market forces. First, the maturation of biologics and complex combination products is raising component complexity, which in turn requires tighter controls, enhanced sterility assurances, and greater precision in component tolerances. This trend is prompting manufacturers to invest in specialized capabilities for handling biologic-grade materials and to partner closely with drug developers to ensure component compatibility.

Second, the adoption of digital quality systems and Industry 4.0 practices is accelerating. Real-time monitoring, predictive maintenance, and data-driven process controls are improving yield and reducing time-to-release, but they also demand significant workforce upskilling and robust cybersecurity postures. Third, supply chain resilience has become a strategic priority following global disruptions; manufacturers are diversifying supplier bases, qualifying secondary sources, and exploring nearshoring options to mitigate single-source risk.

Fourth, sustainability considerations are influencing material selection and packaging design. The drive to reduce plastic use, improve recyclability, and lower carbon footprints is prompting innovation in primary and secondary packaging as well as a reevaluation of material life cycles. Finally, regulatory frameworks are evolving to address new technologies and product classes, increasing the need for proactive regulatory engagement and adaptive compliance strategies. Together, these shifts are creating a more complex but opportunity-rich environment for manufacturers who can integrate technological capabilities with resilient operations and regulatory foresight.

Assessment of how tariff dynamics have reshaped sourcing, procurement, and supply chain resilience strategies for component manufacturers in 2025

The policy environment emanating from tariff actions in the United States in 2025 has added a new dimension to strategic planning across medical component manufacturing, affecting cost structures, supplier selection, and sourcing geography. Tariff measures have introduced incremental cost pressures for components and raw materials sourced from affected jurisdictions, which has prompted buyers to reevaluate supplier contracts, incorporate tariff-adjusted landed costs into procurement models, and accelerate qualification of alternative vendors. These dynamics are particularly impactful for components that rely on specialized alloys, precision polymers, or proprietary subassemblies that have limited global suppliers.

In response to tariff-related uncertainties, many organizations are pursuing multi-pronged responses. Procurement teams are engaging in deeper contract clauses that address tariff pass-through and renegotiation mechanisms, while supply chain leaders are mapping tariff exposures across tiers to identify critical nodes of risk. Parallel efforts include regionalizing supply chains to reduce cross-border tariff exposure, which can yield benefits in lead time and visibility but may require investments in local manufacturing capabilities and quality assurance infrastructure.

Furthermore, manufacturers are reassessing inventory strategies, balancing the operational costs of higher inventory with the benefits of buffering against tariff volatility. This recalibration often involves tighter collaboration between commercial and operations teams to ensure pricing strategies, customer commitments, and margin management reflect the new cost landscape. While tariffs are one of many factors influencing sourcing decisions, their presence has sharpened attention to total landed cost analysis, supplier diversification, and contractual flexibility as cornerstones of resilient component manufacturing strategies.

Detailed segmentation analysis demonstrating how active ingredients, device classes, packaging, diagnostics, instruments, materials, and excipient categories uniquely drive manufacturing and quality priorities

Segment-level intelligence reveals differentiated opportunities and operational priorities that vary by component type, material, and device class. When examining active ingredients, the segmentation distinguishes between Biologics, Biosimilars, and Small Molecules, with Biologics further divided into Monoclonal Antibodies, Recombinant Proteins, and Vaccines. Each of these categories places distinct demands on component design and handling: monoclonal antibodies and recombinant proteins often require low-protein-binding materials and high-integrity seals, whereas vaccines may necessitate specialized primary containers and cold-chain compatible closures.

Within drug delivery devices, the landscape is segmented into Infusion Pumps, Inhalers, Injectors, and Transdermal Patches, and injectors are further categorized as Auto-Injectors, Pen Injectors, and Pre-Filled Syringes. The engineering focus shifts accordingly from flow-path optimization and precision metering in infusion systems to user ergonomics and dosing consistency in injectors and inhalers. Packaging components are delineated into Labeling Solutions, Primary Packaging, and Secondary Packaging; labeling solutions include inserts, labels, and security seals, while primary packaging covers ampoules, blister packs, cartridges, and vials, and secondary packaging encompasses cartons, folding boxes, and multipacks. These distinctions inform priorities around serialization, anti-counterfeiting technology, and tamper-evidence features.

Diagnostic equipment components are considered across biosensor components, imaging components, and lab-on-a-chip platforms, where biosensor types span electrochemical, optical, and piezoelectric sensors, and imaging components include MRI coils, ultrasound transducers, and X-ray tubes. Surgical instruments are segmented into clamps, cutting instruments, grasping instruments, and retractors, with cutting tools further defined by biopsy punches, scalpels, and scissors, and grasping tools including forceps, graspers, and trocars. Biocompatible materials are categorized into ceramics, composites, metals, and polymers, with subtypes such as alumina, bioactive glass, zirconia, metal matrix composites, polymer matrix composites, cobalt chromium alloys, stainless steel, titanium alloys, elastomers, thermoplastics, and thermosets each presenting unique machining, sterilization, and surface finishing considerations. Finally, excipients are segmented into binders, coatings, disintegrants, fillers, and lubricants, with specific chemistries such as HPMC, povidone, starch derivatives, enteric and film coatings, cross-linked disintegrants, cellulose and lactose fillers, and lubricants like magnesium stearate and PEG influencing formulation compatibility and downstream processing.

These segment-specific nuances underscore the need for targeted manufacturing capabilities and quality controls. Transitioning from concept to commercial production requires alignment of material science expertise, component design validation, and supplier qualification tailored to the distinct technical and regulatory requirements of each segment. Manufacturers that invest in deep capabilities across critical segments, while maintaining agility to adapt to cross-segment demands, will be better positioned to meet evolving customer expectations and complex product specifications.

Regional strategic implications for sourcing, regulatory engagement, manufacturing footprints, and supplier development across Americas, EMEA, and Asia-Pacific markets

Regional dynamics exert a strong influence over sourcing strategies, regulatory compliance pathways, and innovation ecosystems. In the Americas, established manufacturing clusters and a mature regulatory environment create advantages for near-market production of high-complexity components and rapid commercialization. The region's ecosystem supports integrated workflows from component design through clinical supply, and it benefits from proximity to major pharmaceutical and biotech centers that require responsive supply chains and robust quality systems.

Europe, Middle East & Africa presents a heterogeneous landscape characterized by stringent regulatory expectations in many European markets, well-developed advanced manufacturing capabilities, and growing investment in digital health across the Middle East. This region's regulatory rigor encourages early and ongoing engagement with conformity assessment processes, and advanced material suppliers in Europe often lead in specialty alloys and biocompatible ceramics. The diversity across these markets requires flexible commercial approaches and localized compliance strategies to address varied market entry conditions and procurement norms.

Asia-Pacific continues to be a focal point for manufacturing scale, both in terms of established contract manufacturers and emerging local suppliers with competitive cost structures. The region offers advantages for large-volume components and for materials sourcing, while increasing domestic regulatory sophistication is driving higher expectations for quality management systems. As such, companies operating across Asia-Pacific must balance cost efficiencies with investments in supplier development, quality assurance, and logistics to ensure reliable supply to global and regional customers. Understanding these regional distinctions supports informed decisions about production footprints, supplier partnerships, and investment priorities.

Competitive landscape insights emphasizing technical depth, operational excellence, integrated offerings, and strategic partnerships shaping market leadership

Competitive dynamics among companies in component manufacturing are shaped by their ability to combine technical depth with scalable production and robust quality frameworks. Leading firms are distinguishing themselves through investments in advanced materials science, precision manufacturing technologies, and integrated validation capabilities that reduce time-to-market for complex components. Strategic partnerships between component manufacturers and drug or device developers are increasingly common, facilitating early-stage design-for-manufacturing input and smoother regulatory trajectories.

Operational excellence remains a differentiator; manufacturers that demonstrate consistent yields, validated supply chains, and comprehensive documentation can secure long-term contracts and premium positioning. At the same time, innovation in packaging and anti-counterfeiting measures, such as secure labeling and serialization techniques, is providing commercial leverage for companies that can ensure product integrity across distribution channels. Investments in automation and digital quality systems are enabling higher throughput while maintaining traceability and compliance, which is particularly attractive to customers with complex combination products or biologic therapies.

Another axis of competition is the ability to offer end-to-end solutions that span materials, component fabrication, assembly, and packaging. Players that can bundle these capabilities reduce integration risk for customers and accelerate program timelines. Finally, agility in responding to policy shifts, such as tariff changes, and in scaling capacity to meet demand surges, marks companies that are best positioned to expand their market presence. Collectively, these capabilities define the competitive contours and provide a roadmap for firms seeking to enhance market relevance and resilience.

Actionable strategic initiatives for executives to strengthen materials capability, supplier resilience, digital quality systems, sustainability, and regulatory engagement

Industry leaders must act decisively to align capability investments with the evolving requirements of complex therapies and devices. First, prioritize investments in specialized material handling and manufacturing capabilities for biologic-compatible components and high-precision imaging and sensor parts, ensuring facilities and personnel are qualified for aseptic processing, tight tolerances, and validated sterilization methods. Second, strengthen supplier diversification and qualification programs to mitigate tariff-driven exposures and single-source risks, and integrate total landed cost models into procurement decision-making to capture hidden cost drivers.

Third, accelerate digital transformation initiatives that support real-time quality monitoring, predictive maintenance, and end-to-end traceability, while establishing clear programs for workforce reskilling to leverage these technologies. Fourth, embed sustainability criteria into material selection and packaging design to meet purchaser expectations and regulatory pressures, and consider circular-economy principles where appropriate. Fifth, enhance regulatory engagement strategies by mapping regulatory pathways early in development and maintaining proactive dialogue with certification bodies to streamline market access for complex components and combination products.

Finally, pursue strategic partnerships that enable co-development, shared validation efforts, and faster commercialization. Whether through supplier alliances, academic collaborations, or contract development arrangements, these partnerships can accelerate capability building while spreading risk. Executives who balance short-term resilience measures with long-term investments in technology, people, and partnerships will position their organizations to capitalize on demand for increasingly sophisticated medical components.

Description of a mixed-methods research approach combining stakeholder interviews, factory validation, regulatory review, and analytical frameworks to produce actionable insights

This research synthesizes qualitative and quantitative inputs derived from primary and secondary information streams to produce a structured analysis of manufacturing, supply chain, segmentation, regional dynamics, and competitive positioning. Primary inputs included interviews with manufacturing leaders, quality and regulatory professionals, procurement executives, and product development specialists, which provided firsthand perspectives on operational challenges, capability requirements, and strategic priorities. These interviews were complemented by factory observations and technology profiling to validate capability claims and to assess practical implications of manufacturing processes and material choices.

Secondary research encompassed a review of regulatory guidance documents, standards for medical device and pharmaceutical component manufacturing, industry white papers, and technical literature on advanced materials and diagnostics components. The methodology incorporated cross-validation between primary insights and documented standards to ensure factual accuracy and to identify emergent best practices. Analytical frameworks used include segmentation-based capability mapping, supply chain exposure assessment, and technology readiness evaluation to contextualize operational implications for each component class.

To preserve objectivity, the study applied consistent criteria for supplier assessment, including manufacturing capability, quality system maturity, and track record in regulated markets. Limitations were acknowledged where proprietary data or rapidly evolving regulatory positions constrained interpretability, and recommendations were framed to be robust under reasonable variation in market conditions. Together, these methods underpin a synthesis intended to inform strategic and operational decision-making for manufacturers and their partners.

Concluding synthesis highlighting the need for capability integration, supply chain resilience, and regulatory alignment to secure long-term competitive advantage

The medical component manufacturing sector is navigating a period of accelerated complexity and opportunity. Technological advancements in materials, additive manufacturing, sensors, and digital quality systems are enabling higher-performance components, while regulatory expectations and sustainability imperatives are raising the bar for compliance and lifecycle thinking. Supply chain disruptions and trade policy shifts have underscored the importance of diversified sourcing strategies and rigorous risk management. Against this backdrop, manufacturers that integrate deep technical capabilities with resilient operations and proactive regulatory engagement will capture the most durable advantages.

Leaders should embrace a portfolio approach that balances investments in near-term resilience-such as supplier diversification and tariff-aware procurement-with long-term capability building in advanced materials and digital manufacturing. Cross-functional collaboration between engineering, quality, regulatory, and commercial teams will be essential to convert innovation into scalable, compliant products. By aligning strategic investments with segment-specific requirements and regional realities, organizations can reduce time-to-market, improve product reliability, and strengthen customer partnerships.

In sum, the path forward requires disciplined execution across technology, operations, and governance. Manufacturers that act with clarity and intentionality, while maintaining the flexibility to adapt to evolving clinical and policy landscapes, will establish positions of sustained competitiveness in the medical component ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing use of biocompatible 3D printed materials for patient-specific implants and devices
  • 5.2. Emerging regulations on antimicrobial surface coatings for high-touch medical device components
  • 5.3. Shift toward miniaturized wearable sensors integrating flexible electronic component manufacturing
  • 5.4. Escalating demand for silicone-based seals and tubing in critical care and diagnostic equipment
  • 5.5. Investment in automated precision machining for stainless steel surgical instrument components
  • 5.6. Supply chain resilience strategies for rare earth metals used in medical imaging hardware
  • 5.7. Development of bioresorbable polymer blends for temporary orthopedic fixation devices
  • 5.8. Integration of IoT-enabled microcontrollers in disposable medical diagnostic cartridges
  • 5.9. Sustainability initiatives promoting recyclable packaging components for medical devices

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Component Manufacturing Market, by Active Ingredients

  • 8.1. Biologics
    • 8.1.1. Monoclonal Antibodies
    • 8.1.2. Recombinant Proteins
    • 8.1.3. Vaccines
  • 8.2. Biosimilars
  • 8.3. Small Molecules

9. Medical Component Manufacturing Market, by Drug Delivery Devices

  • 9.1. Infusion Pumps
  • 9.2. Inhalers
  • 9.3. Injectors
    • 9.3.1. Auto-Injectors
    • 9.3.2. Pen Injectors
    • 9.3.3. Pre-Filled Syringes
  • 9.4. Transdermal Patches

10. Medical Component Manufacturing Market, by Packaging Components

  • 10.1. Labeling Solutions
    • 10.1.1. Inserts
    • 10.1.2. Labels
    • 10.1.3. Security Seals
  • 10.2. Primary Packaging
    • 10.2.1. Ampoules
    • 10.2.2. Blister Packs
    • 10.2.3. Cartridges
    • 10.2.4. Vials
  • 10.3. Secondary Packaging
    • 10.3.1. Cartons
    • 10.3.2. Folding Boxes
    • 10.3.3. Multipacks

11. Medical Component Manufacturing Market, by Diagnostic Equipment Components

  • 11.1. Biosensor Components
    • 11.1.1. Electrochemical Sensors
    • 11.1.2. Optical Sensors
    • 11.1.3. Piezoelectric Sensors
  • 11.2. Imaging Components
    • 11.2.1. MRI Coils
    • 11.2.2. Ultrasound Transducers
    • 11.2.3. X-Ray Tubes
  • 11.3. Lab On A Chip

12. Medical Component Manufacturing Market, by Surgical Instruments

  • 12.1. Clamps
  • 12.2. Cutting Instruments
    • 12.2.1. Biopsy Punches
    • 12.2.2. Scalpels
    • 12.2.3. Scissors
  • 12.3. Grasping Instruments
    • 12.3.1. Forceps
    • 12.3.2. Graspers
    • 12.3.3. Trocars
  • 12.4. Retractors

13. Medical Component Manufacturing Market, by Biocompatible Materials

  • 13.1. Ceramics
    • 13.1.1. Alumina
    • 13.1.2. Bioactive Glass
    • 13.1.3. Zirconia
  • 13.2. Composites
    • 13.2.1. Metal Matrix Composites
    • 13.2.2. Polymer Matrix Composites
  • 13.3. Metals
    • 13.3.1. Cobalt Chromium Alloys
    • 13.3.2. Stainless Steel
    • 13.3.3. Titanium Alloys
  • 13.4. Polymers
    • 13.4.1. Elastomers
    • 13.4.2. Thermoplastics
    • 13.4.3. Thermosets

14. Medical Component Manufacturing Market, by Excipients

  • 14.1. Binders
    • 14.1.1. HPMC
    • 14.1.2. Povidone
    • 14.1.3. Starch
  • 14.2. Coatings
    • 14.2.1. Enteric Coating
    • 14.2.2. Film Coating
    • 14.2.3. Sugar Coating
  • 14.3. Disintegrants
    • 14.3.1. Cross Carmellose
    • 14.3.2. Cross Povidone
    • 14.3.3. Sodium Starch Glycolate
  • 14.4. Fillers
    • 14.4.1. Cellulose
    • 14.4.2. Lactose
    • 14.4.3. Starches
  • 14.5. Lubricants
    • 14.5.1. Magnesium Stearate
    • 14.5.2. PEG
    • 14.5.3. Stearic Acid

15. Medical Component Manufacturing Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Medical Component Manufacturing Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Medical Component Manufacturing Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Medtronic plc
    • 18.3.2. Abbott Laboratories
    • 18.3.3. Johnson & Johnson
    • 18.3.4. Siemens Healthineers AG
    • 18.3.5. GE HealthCare Technologies Inc
    • 18.3.6. Koninklijke Philips N.V.
    • 18.3.7. Becton Dickinson and Company
    • 18.3.8. Stryker Corporation
    • 18.3.9. Baxter International Inc
    • 18.3.10. Boston Scientific Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ACTIVE INGREDIENTS, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ACTIVE INGREDIENTS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PACKAGING COMPONENTS, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PACKAGING COMPONENTS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT COMPONENTS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT COMPONENTS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY EXCIPIENTS, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY EXCIPIENTS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. MEDICAL COMPONENT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. MEDICAL COMPONENT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL COMPONENT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ACTIVE INGREDIENTS, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INHALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INHALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INHALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INHALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INHALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INJECTORS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INJECTORS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INJECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INJECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INJECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INJECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INJECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INJECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PEN INJECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PEN INJECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PEN INJECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PEN INJECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PEN INJECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY TRANSDERMAL PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY TRANSDERMAL PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PACKAGING COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PACKAGING COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELING SOLUTIONS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELING SOLUTIONS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELING SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELING SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELING SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELING SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELING SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELING SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INSERTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INSERTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INSERTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INSERTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INSERTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY INSERTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LABELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECURITY SEALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECURITY SEALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECURITY SEALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECURITY SEALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECURITY SEALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECURITY SEALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTRIDGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTRIDGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CARTONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FOLDING BOXES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FOLDING BOXES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FOLDING BOXES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FOLDING BOXES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FOLDING BOXES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FOLDING BOXES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MULTIPACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MULTIPACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MULTIPACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MULTIPACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MULTIPACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MULTIPACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSENSOR COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSENSOR COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSENSOR COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSENSOR COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSENSOR COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSENSOR COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSENSOR COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOSENSOR COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY OPTICAL SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY OPTICAL SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY OPTICAL SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY OPTICAL SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY OPTICAL SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY OPTICAL SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PIEZOELECTRIC SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PIEZOELECTRIC SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PIEZOELECTRIC SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PIEZOELECTRIC SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PIEZOELECTRIC SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY PIEZOELECTRIC SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY IMAGING COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY IMAGING COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY IMAGING COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY IMAGING COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY IMAGING COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY IMAGING COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY IMAGING COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY IMAGING COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MRI COILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MRI COILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MRI COILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MRI COILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MRI COILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY MRI COILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ULTRASOUND TRANSDUCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ULTRASOUND TRANSDUCERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ULTRASOUND TRANSDUCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ULTRASOUND TRANSDUCERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ULTRASOUND TRANSDUCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY ULTRASOUND TRANSDUCERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY X-RAY TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY X-RAY TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY X-RAY TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY X-RAY TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY X-RAY TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY X-RAY TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LAB ON A CHIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LAB ON A CHIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LAB ON A CHIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LAB ON A CHIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LAB ON A CHIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY LAB ON A CHIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CLAMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CLAMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CLAMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CLAMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CLAMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CLAMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CUTTING INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CUTTING INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CUTTING INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CUTTING INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CUTTING INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CUTTING INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CUTTING INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY CUTTING INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOPSY PUNCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOPSY PUNCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOPSY PUNCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOPSY PUNCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOPSY PUNCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY BIOPSY PUNCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCALPELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCALPELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCALPELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCALPELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCALPELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCALPELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCISSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCISSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCISSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCISSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCISSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY SCISSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GRASPING INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GRASPING INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GRASPING INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GRASPING INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GRASPING INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GRASPING INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GRASPING INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GRASPING INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FORCEPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FORCEPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FORCEPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FORCEPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FORCEPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY FORCEPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL MEDICAL COMPONENT MANUFACTURING MARKET SIZE, BY GRASPERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL MEDICAL COMPONENT MANUF